Format

Send to

Choose Destination
Gastroenterol Hepatol (N Y). 2018 Apr;14(4):233-239.

Evaluation of Dysplasia in Barrett Esophagus.

Author information

1
Dr Gross is an associate professor of medicine, Dr Kingsbery and Dr Jang are resident physicians, and Dr Lee and Dr Khan are assistant professors of medicine in the Division of Gastroenterology and Hepatology at NYU Langone Health in New York, New York.

Abstract

Barrett esophagus (BE) is the precursor lesion to adenocarcinoma of the esophagus. The current surveillance strategy of 4-quadrant Seattle protocol biopsies has been associated with sampling error and missing higher-risk lesions, and there is often less adherence to endoscopic surveillance with long segments. Advancements in endoscopic imaging and sampling techniques allow for better surveillance of BE, particularly when assessing for dysplasia. This article highlights the key endoscopic imaging and sampling advancements in the evaluation of dysplasia in BE.

KEYWORDS:

Barrett esophagus; chromoendoscopy; confocal laser endomicroscopy; dysplasia; narrow-band imaging; volumetric laser endomicroscopy

PMID:
29942221
PMCID:
PMC6009185

Conflict of interest statement

The authors have no relevant conflicts of interest to disclose.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center